UOC
PRCT icon

UBS O'Connor’s Procept Biorobotics PRCT Stock Holding History

UBS O'Connor’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,000
Closed -$27.4K – 442
2025
Q1 		$27.4K Buy
+15,000
New +$1.02M ﹤0.01% 298

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

UBS O'Connor's PRCT Position: Q3 2025 in Review

UBS O'Connor sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 25,226 shares — an estimated $1.45M sold.

UBS O'Connor first reported a position in PRCT in Q4 2022 and held it in 8 quarters. The position peaked at $1.81M in Q2 2023. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • UBS O'Connor reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 25,226 Procept Biorobotics shares in Q3 2025, an estimated $1.45M.
  • UBS O'Connor first reported a position in Procept Biorobotics in Q4 2022 and held it in 8 quarters.
  • UBS O'Connor's Procept Biorobotics position peaked at $1.81M in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.